Nasdaq declared stressed market conditions for Genmab derivatives on October 26, 2026, allowing market makers to quote wider spreads for four hours. The exchange said it would then assess whether the conditions remained valid.
What changes for Genmab derivatives
During the stressed market period, market makers are permitted to quote prices with twice the normal spread. The declaration applies to derivatives on Genmab, identified by the symbol GEN.
The announcement did not specify a start time or say what had triggered the declaration.
When Nasdaq calls stressed conditions
Nasdaq said stressed conditions are called when an underlying asset experiences high, short-term intraday volatility or when other factors create significant uncertainty in pricing derivatives.
The four-hour period is subject to a subsequent assessment; the announcement did not say whether the conditions would be extended.
Read More News
Disclaimer
This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.
Comments
Be respectful. No spam, impersonation or private credentials. Ordinary posts and comments appear immediately; suspicious links are held for review.
Please wait…